Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

The outcome of liver transplantation in autoimmune hepatitis

U Ołdakowska-Jedynak, P Nyckowski, K Zieniewicz, T Wróblewski, R Paluszkiewicz, B Górnicka, B Ziarkiewicz-Wróblewska, L Pączek, B Foroncewicz, A Kącka, , M Krawczyk

Ann Transplant 2009; 14(1): 29-29 :: ID: 880304

Abstract

Autoimmune hepatitis (AIH) is an indication for liver transplantation (OLTx).
OLTx is offered to patients with fulminant or subfulminant and patients with
decompensated liver cirrhosis, but its post-transplant course remains controversial and pts transplanted for AIH comprise a group of special interest. The aim of this study was to evaluate clinical outcome after OLTx in these patients at a single institution. Patients and methods. Retrospective data was collected from pts transplanted at our centre from December 1989 until January 2004. A total of 256 OLTx was performed. 12 pts were transplanted for AIH. There were 3 men and 9 women. This patient cohort comprised 5% of the total transplants over that period. All pts presented with type I AIH. Initial immunosuppressive medication was induction with the use of basiliximab 20 mg on day 0 and 4 in combination with tacrolimus-based regimen in most cases. Steroid therapy was never discontinued during the study period. We did not perform protocol liver biopsies. Results. Mean age of recipients was 30.3±10.9 years-old. They are younger than recipients transplanted for another causes than AIH 40.4±11.8 years-old, and mostly female. Autoantibodies and hypergammaglobulinemia disappeared in most pts within 2 years. Acute rejection (AR) episode was not frequent and occurred in 27% of pts. There was no correlation between antibodies persistence and graft rejection episodes. No recurrence of AIH was observed during the follow-up after OLTx. One pt developed clinical symptoms with presumed recurrence which was not confi rmed by biopsy. However, the majority of this pts' group experienced high incidence, at least one episode, of bacterial infection 82% (9 pts) and CMV infection 73% (8 pts). The patient's and graft's survival rates for this group at 1, 5 and 7 years was 92%, 81.5%, 81.5% and 83%, 73%, 73% respectively.

Keywords: Liver Transplantation, clinical outcome

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358